As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
July is National Cord Blood Awareness Month
July 03, 2025
FDA Eliminates REMS for Approved CAR T-Cell Therapies
June 30, 2025
12th Edition of Standards for Cellular Therapy Services Takes Effect July 1
June 25, 2025